瀚川智能(688022.SH):與悦享雄安攜手助力建設新能源重卡市場展開合作
格隆匯3月20日丨瀚川智能(688022.SH)公佈,公司與悦享雄安本着“互惠互利”“穩定恒久”“高效優質”“共同發展”的合作精神,雙方出於長遠發展戰略考慮,決定共同合作,攜手助力建設新能源重卡市場。雙方經友好協商,達成戰略合作意向並簽署了《戰略合作框架協議》。
公司依託核心技術優勢研發了商用車充換電站、換電核心部件和運營終端,在商用車換電站設備的智能化程度、設備運行穩定性、批量交付能力等指標和售後服務能力方面具有領先優勢,本次戰略合作協議的簽署也標誌着公司商用車換電站設備受到行業客户的認可。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.